Statistics for Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays
Total visits
| views | |
|---|---|
| Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays | 73 |
Total visits per month
| views | |
|---|---|
| November 2024 | 5 |
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Proactive therapeutic drug monitoring of infliximab.pdf(legacy) | 300 |
| Proactive therapeutic drug monitoring of infliximab.pdf | 22 |
Top country views
| views | |
|---|---|
| United States | 37 |
| China | 21 |
| Brazil | 2 |
| Hong Kong SAR China | 2 |
| Portugal | 2 |
| Ukraine | 2 |
| Canada | 1 |
| Switzerland | 1 |
| Germany | 1 |
| France | 1 |
| United Kingdom | 1 |
| India | 1 |
| South Korea | 1 |